Frederik Wenz, MD CHICAGO—Bone remodeling markers may be useful for diagnosing and following prostate and breast cancer patients with bone metastases, according to researchers. Baseline levels of ICTP ...

A phase I study of IPH2101, a novel anti-inhibitory KIR monoclonal antibody, in patients with multiple myeloma. Background: Aminobisphosphonates (aBP) are standard of care for myeloma related bone ...

Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases Results from Studies of Other Investigational Merck Cancer ...

An expert working group of the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has released a new position paper which ...

Please provide your email address to receive an email when new articles are posted on . Results showed bone quality was abnormal in ankle arthritis on the affected side. However, bone quality was ...

Please provide your email address to receive an email when new articles are posted on . SANTA FE, N.M. — In this video exclusive, Jacques P. Brown, MD, discusses clinical applications of bone turnover ...

Tumor suppressor genes (TSG), treatment, and survival in de novo metastatic hormone-sensitive prostate cancer. Multivariate Cox proportional hazard model for PFS and OS. Bone Pain (yes vs No) 1.52, ...

Aging and lifestyle-related metabolic imbalances, such as hyperglycemia, hyperlipidemia, and oxidative-stress, cause the accumulation of advanced glycation end products (AGEs), including pentosidine ...

Background Psoriatic disease has a complex effect on bone metabolism, resulting in both pathological bone formation and bone resorption. However, microstructural changes in cortical and trabecular ...

Youths with type 1 diabetes (T1D) show lower bone accrual than expected for their age, gender, pubertal stage, lean mass accrual, and growth, with greater urinary calcium excretion being associated ...